We will rely on you to help lend your voice and support the biotechnology industry.
Bringing new treatments to patients, support public policies that promote innovation, improve patient access.
BIO Latin America Conference
September 4-5, 2018
BIO Investor Forum
October 17-18, 2018
BIO Industry Analysis Reports >>
Save. Advocate. Connect. Join Us.
A listing of all BIO members and subsidiaries.
October 17 - 18, 2018 | San Francisco, California
KT Moortgat, Ph.D., joined AbbVie Ventures in 2017 to build the west coast investment efforts. She is an enabler of technology translation, through startup incubation, investment, and partnering.
Prior to joining AbbVie, she was CEO of a microbiome therapeutics company through the funding and launch of a multi-site Phase 2b study of its lead product candidate, and held other leadership positions in venture-backed life science companies.
Previously, KT was a partner at the venture capital firm Mohr Davidow Ventures (MDV) for six years. She also founded and led the hub of entrepreneurship at QB3 and the University of California San Francisco. KT earned her bachelor’s degree from University of California, Berkeley. She earned her doctorate degree at the Salk Institute.
This speaker's sessions: